Perkins Adelene Q

Director at INFINITY PHARMACEUTICALS, INC.

Sold, on record
$2.3M
Dollars the filings state
Form 4 sales
10
Latest Sep 12, 2023
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale INFINITY PHARMACEUTICALS, INC.Plan not stated
    Mar 5, 2015 2015

    Sold 25,000 shares at $16.50 ($413k)

    Perkins Adelene Q, President & CEO

    Sold 5.8% of holdings ($7.1M position)404,432 shares leftFiling

  2. 2 Form 4 sale INFINITY PHARMACEUTICALS, INC.Plan not stated
    Mar 16, 2015 +11 days

    Sold 20,000 shares at $16.00 ($320k)

    Perkins Adelene Q, President & CEO

    Sold 4.9% of holdings ($6.5M position)384,432 shares left0.8x usual sizeFiling

  3. 3 Form 4 sale INFINITY PHARMACEUTICALS, INC.Plan not stated
    May 14, 2015 +59 days

    Sold 10,000 shares at $12.18 ($122k)

    Perkins Adelene Q, President & CEO

    Sold 2.6% of holdings ($4.7M position)374,432 shares left0.4x usual sizeFiling

  4. 4 Form 4 sale INFINITY PHARMACEUTICALS, INC.Plan not stated
    May 27, 2015 +13 days

    Sold 10,000 shares at $12.81 ($128k)

    Perkins Adelene Q, President & CEO

    Sold 2.7% of holdings ($4.8M position)364,432 shares left0.5x usual sizeFiling

  5. 5 Form 4 sale INFINITY PHARMACEUTICALS, INC.Plan not stated
    Jun 25, 2015 +29 days

    Sold 5,000 shares at $10.93 ($55k)

    Perkins Adelene Q, President & CEO

    Sold 1.4% of holdings ($4M position)359,432 shares left0.3x usual sizeFiling

  6. 6 Form 4 sale INFINITY PHARMACEUTICALS, INC.Plan not stated
    Mar 5, 2018 +984 days

    Sold 5,000 shares at $2.78 ($14k)

    Perkins Adelene Q, Chief Executive Officer

    Sold 0.8% of holdings ($1.7M position)607,252 shares leftFirst sale on recordFiling

  7. 7 Form 4 sale INFINITY PHARMACEUTICALS, INC.Plan not stated
    Oct 1, 2018 +210 days

    Sold 5,000 shares at $2.82 ($14k)

    Perkins Adelene Q, Chief Executive Officer

    Sold 0.8% of holdings ($1.7M position)609,561 shares leftFiling

  8. 8 Form 4 sale INFINITY PHARMACEUTICALS, INC.Routine
    Sep 12, 2023 +1807 days

    Sold 410,196 shares at $0.0700 ($29k)

    Perkins Adelene Q, Director

    10b5-1 planSold 25.9% of holdings ($111k position)1.2M shares leftFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (10)

Form 144 notices and Form 4 sales by Perkins Adelene Q
Source
Sep 12, 2023Sep 12, 2023INFINITY PHARMACEUTICALS, INC.DirectorForm 4 sale410,196$29k25.9%RoutineSEC
Oct 1, 2018Oct 2, 2018INFINITY PHARMACEUTICALS, INC.Chief Executive OfficerForm 4 sale5,000$14k0.8%Plan not statedSEC
Mar 5, 2018Mar 7, 2018INFINITY PHARMACEUTICALS, INC.Chief Executive OfficerForm 4 sale5,000$14k0.8%Plan not statedSEC
Jun 25, 2015Jun 26, 2015INFINITY PHARMACEUTICALS, INC.President & CEOForm 4 sale5,000$55k1.4%Plan not statedSEC
May 27, 2015May 28, 2015INFINITY PHARMACEUTICALS, INC.President & CEOForm 4 sale10,000$128k2.7%Plan not statedSEC
May 14, 2015May 15, 2015INFINITY PHARMACEUTICALS, INC.President & CEOForm 4 sale10,000$122k2.6%Plan not statedSEC
Mar 16, 2015Mar 17, 2015INFINITY PHARMACEUTICALS, INC.President & CEOForm 4 sale20,000$320k4.9%Plan not statedSEC
Mar 5, 2015Mar 9, 2015INFINITY PHARMACEUTICALS, INC.President & CEOForm 4 sale25,000$413k5.8%Plan not statedSEC
Jan 29, 2015Feb 2, 2015INFINITY PHARMACEUTICALS, INC.President & CEOForm 4 sale20,000$297k4.5%Plan not statedSEC
Sep 13, 2013Sep 13, 2013INFINITY PHARMACEUTICALS, INC.Pres & Chief Executive OfficerForm 4 sale45,000$932k9.1%Plan not statedSEC